Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Fibroblast Growth Factor Receptor 3 (FGFR3) is a transmembrane receptor tyrosine kinase that plays a crucial role in regulating cell growth, differentiation, and development. It is involved in various processes including bone growth, angiogenesis, and tumorigenesis. Mutations in FGFR3 are associated with skeletal dysplasias like achondroplasia and cancers such as bladder urothelial carcinoma. Targeting FGFR3 is of therapeutic interest, with drugs like erdafitinib showing efficacy against specific mutations.
Tyrosine kinase inhibitors, FGFR inhibitors
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fibroblast Growth Factor Receptor 3 (FGFR3).